Efficacy of a One-a-Day L. Reuteri NCIMB 30242 Probiotic Supplement Capsule

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 150 participants.

Also called NCT01630668

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 150 participants (enrolled count) (from the registry)
Sponsor
Micropharma Limited (from the registry)
Registry
  • NCT NCT01630668
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01630668. Randomized; double masking; primary purpose treatment. Start 2012-08 (registry gives no type); primary completion 2013-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy of a One-a-Day L. Reuteri NCIMB 30242 Probiotic Supplement Capsule
Condition
Hypercholesterolemia
Intervention (Dietary supplement)
One-a-Day L. reuteri NCIMB 30242 supplement capsule
Intervention (Dietary supplement)
One-a-Day placebo capsule
Lead sponsor
Micropharma Limited (class: industry)

Record details

Record id
cardio:ct-nct01630668
Content hash
c884cf25b943cb2d77e8d9cfd3b1e6f9ef3c516d4de3af3a69feab5bf8c0b344